Profile
Last Updated On: 20 September 2011
Fast Facts
| Country | Egypt | ||||||||||
| Ownership Type | Publicly Listed | ||||||||||
| Stock Market Listing |
|
Zawya Industry Classifications (ZIC)
| Sector (Definitions) | Industry |
|---|---|
| Health Care |
Contact Details
| Address |
October Pharma Building 6 October Industrial Zone 1 38 Egypt | |
| City: |
Cairo
|
|
| City Suffix: |
12566
|
|
| Tel: |
+20 2-3912-3855
+20 2-3833-0652 |
|
| Fax: |
+20 2-3779-8123
+20 2-3833-0653 |
|
| Email: |
opharma@octoberpharma.com
|
|
| Region: |
Cairo
|
-
Begin your journey with a Zawya membership.
Key Features:
- Over 23,300 company profiles with 290,980+ officers
- Comprehensive equity capital market data
- Zawya Dow Jones live news and over 300 aggregated news sources
- Company, Sector, Market, and Macro Research
- Investment intelligence including Funds, Sukuk, Private Equity, M&A, IPO and Bonds
- Over 5,710 in-depth Project Reports and Monitoring
- Up-to-date construction and non-construction tender issues
- Community tools Zawya Network, Events, Blogs and more
- Intuitive tools to customize your experience with support & training
- Full fledged access to Analytical tools such as Companies Monitor
Learn More Already a member? Sign In
-
For US$ 29 only , the following premium intelligence is available on this company:
- Date of Establishment
- Operations
- Major Shareholders
Date when company was registered as a legal entity.
Includes Principal Activities, No of Employees, Total Production Capacity and Brands.
- Summary of Financial Results
- Representatives
- Executives and Board of Directors
Includes the following summary of financial results: Shares outstanding, Total assets, Net profit, Total revenues, Shareholders' Equity, Paid-up capital and Market capitalization.
Includes Banks, Law Firms, External Auditors.
Lists Board Members and Top Executives
Company information provided by © 2013 Zawya.
Zawya's analysts update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Our researchers then validate this information and source further information by contacting the companies directly.
